Pulmonary Aspergillosis

This is an infection in the lungs caused by a type of mold called Aspergillus. It can happen in people with weakened immune systems or those with underlying lung conditions. The infection can range from mild to severe.

Condition

What people with Pulmonary Aspergillosis report

Every report comes from a Lived member, sent anonymously.

Have you tried Vfend (Voriconazole) for Pulmonary Aspergillosis?

NameHow it went

About Pulmonary Aspergillosis

What It Is

Pulmonary aspergillosis is lung disease caused by Aspergillus, a mold that grows on soil, compost, dead leaves and stored grain. Most people breathe in its microscopic spores every day without any effect, because a healthy immune system clears them. Illness happens when the lungs are already damaged or the body's defenses are weakened, and the form it takes depends on which of those is true. There are three main forms, and they behave very differently. Allergic bronchopulmonary aspergillosis (ABPA) is an allergic reaction to the mold in the airways, mostly in people with asthma or cystic fibrosis. It causes wheezing, cough and sometimes brownish plugs of mucus, rather than an infection of the lung tissue. Chronic pulmonary aspergillosis is a slow infection that develops over months in lungs scarred by earlier disease. It includes the aspergilloma, or fungus ball, a clump of mold that grows inside an old lung cavity. Invasive pulmonary aspergillosis is a fast, serious infection that grows into lung tissue and can spread to other organs. It affects people whose immune systems are severely weakened, and it needs urgent treatment.

Causes & Risk Factors

Exposure to Aspergillus is nearly universal, so the important risk factors are about the person rather than the environment. Invasive disease mainly affects people with weakened immunity: those receiving chemotherapy for leukemia or other blood cancers, stem cell or organ transplant recipients (especially lung transplant), people taking high doses of steroids or other immune-suppressing medicines, and some people with advanced HIV. Very low white blood cell counts after chemotherapy are a particularly strong risk. It also occurs in people critically ill in intensive care, especially with severe influenza or COVID-19, advanced COPD (chronic obstructive pulmonary disease) or liver failure. Chronic infection and fungus balls usually develop in people with fairly normal immunity who have existing lung damage, most often from past tuberculosis, COPD, earlier lung surgery or other scarring. ABPA develops in people with asthma or cystic fibrosis whose immune systems overreact to the mold. Heavy exposure, such as handling compost or moldy hay, may trigger flare-ups in people who are already sensitized, but it is not a cause on its own in healthy lungs.

How It's Diagnosed

Because the forms differ so much, diagnosis starts with the person's health background, symptoms and a CT scan of the chest, which shows nodules, cavities, fungus balls or plugged, widened airways far better than a plain X-ray. For suspected invasive disease, speed matters. Doctors may test blood or fluid washed from the lungs during a bronchoscopy (a thin camera passed into the airways) for galactomannan, a sugar released by growing Aspergillus. They may also culture the mold or look for its genetic material with a PCR test. A positive result in a high-risk person supports the diagnosis, but a negative result does not fully rule it out, so treatment often begins while results are pending. Chronic pulmonary aspergillosis is diagnosed when cavities or nodules on imaging, evidence of Aspergillus (usually a blood test for Aspergillus antibodies, which is positive in more than 90% of cases, or the mold in a sample) and the absence of another explanation have all been present for at least three months. Tuberculosis and lung cancer can look similar and need to be excluded. ABPA is diagnosed in someone with asthma or cystic fibrosis using blood tests: an allergy antibody (IgE) specific to Aspergillus, a high total IgE level (generally 500 IU/mL or more), and supporting findings such as Aspergillus IgG antibodies, raised eosinophils (an allergy-related white blood cell) or typical CT changes.

Treatment Options

Treatment depends on the form, and getting the form right is the first step. Invasive pulmonary aspergillosis needs antifungal medicine started quickly. Voriconazole (Vfend), a triazole antifungal, has been the standard first choice for two decades; isavuconazole (Cresemba) is a similar alternative, and liposomal amphotericin B is an option when these cannot be used. Treatment usually starts in the hospital, often through an IV, and is switched to pills once the person is stable. It typically continues for at least 6 to 12 weeks, and longer while the immune system remains weak. Recovery of the immune system, for example when white blood cell counts return after chemotherapy, matters as much as the drug. Chronic pulmonary aspergillosis is usually treated with months of oral itraconazole or voriconazole to ease cough, fatigue and weight loss, stop bleeding and keep the disease from progressing. A single fungus ball that causes bleeding may be removed surgically when the person is fit for surgery, which can be curative; one that causes no symptoms is often watched instead. Coughing up blood can be controlled with tranexamic acid (a medicine that helps blood clot) or bronchial artery embolization, a procedure that blocks the bleeding vessel from inside. ABPA is treated by calming the allergic reaction. A course of oral steroids such as prednisone, or the antifungal itraconazole, is used for a new diagnosis or a flare, and the two are combined for repeated flares. For people who keep needing steroids, biologic asthma injections such as omalizumab (Xolair) can reduce flares and steroid use. Good asthma or cystic fibrosis care remains part of the plan. Triazole antifungals interact with many common medicines, including some heart, cholesterol, seizure and transplant drugs, so the full medicine list needs review. Blood levels of the drug, liver tests and sometimes heart rhythm tracings are checked during treatment.

What to Expect

The course differs greatly by form. Invasive aspergillosis is a serious illness that often requires hospital care, and the outcome depends heavily on how quickly treatment starts and whether the immune system recovers. Chronic pulmonary aspergillosis is a long-term condition. Treatment often lasts six months or more, with symptoms, blood tests and CT scans checked every few months to judge whether it is working. Some people need repeated or ongoing courses, and fatigue, cough and breathlessness can affect work and daily activity. The outlook depends on age, the type of chronic disease and the underlying lung condition; a single fungus ball that is fully removed generally does best. ABPA usually improves with treatment, but flare-ups are common and may need repeat courses. Regular follow-up with breathing tests, IgE levels and imaging helps catch flares early and protects the airways from permanent damage (bronchiectasis). Limiting activities that stir up large amounts of mold, such as turning compost, or wearing a well-fitted N95 mask when they cannot be avoided, may help.

When to Seek Help

See a doctor if you have asthma that becomes harder to control with brownish mucus plugs, or if a cough, fatigue or weight loss persists in someone with past tuberculosis or other lung scarring. If your immune system is weakened by cancer treatment, a transplant or immune-suppressing medicines, contact your care team right away if you develop a fever, a new cough, chest pain or worsening breathlessness. Also contact them promptly if you see streaks of blood in your mucus while being treated for aspergillosis, because it can signal that the infection is not responding. Get emergency care if you cough up more than a few teaspoons of blood or become severely short of breath.

Questions to Ask Your Doctor

  1. 1.Which form of aspergillosis do I have, and how sure are we of the diagnosis?
  2. 2.What is the goal of my treatment, and how will we know if it is working?
  3. 3.How long am I likely to need antifungal medicine, and which of my other medicines could interact with it?
  4. 4.What monitoring will I need while on treatment, and how often?
  5. 5.Is there anything about my home, work or hobbies I should change to reduce mold exposure?

Last reviewed • Oct 2026

Educational content, not medical advice.